Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FE730
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,615
Award facts
- Contract value 100% obligated
- $10,615.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,615.49 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on January 12, 2026, with completion scheduled for January 13, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., serves as a major pharmaceutical distributor for federal medical procurement, with particular emphasis on supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The task order structure and firm fixed-price arrangement reflect the established federal procurement protocols for essential pharmaceutical commodities supporting the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FE730?
SPE2DR26FE730 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FE730 worth?
The government has obligated $10,615 on SPE2DR26FE730.
Is contract SPE2DR26FE730 an order under another contract?
Yes. SPE2DR26FE730 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE730 competed?
The extent of competition for SPE2DR26FE730 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award